this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance


Friday, September 05, 2008

State Legislative Best Practices in Support of Bioscience Industry Development

Click here for a printer-friendly page Printer Friendly
Introduction

Essential Building Blocks for Growth

Glossary of Terms

Complete Report PDF (1.8 MB)

This report was published November 2006.

Role of Partners in Commercialization and Job Creation

As with any economic development activity, a variety of public and private stakeholder groups are essential to provide the significant financing, personnel requirements as well as a supportive business climate needed to successfully compete in today's marketplace. The bioscience industry has three primary partners in this endeavor each providing support in unique ways. They include policymakers, universities and research centers, as well as the industry itself.

Academic Research Centers:
Fostering collaborative partnerships between academic research centers and companies has emerged as a critical imperative in sustaining U.S. invention and innovation. The increasing volume and accelerated pace of knowledge creation has transformed the research process to the point where no one scientist or institution can sufficiently conduct wholly independent research programs. This new reality makes the relationship between academic investigators and industry researchers a central driver in the decades since the passage of the Bayh-Dole Act of 1980.

Policy Makers:
The need for a stable and supportive public policy structure is pivotal to bioscience companies large and small. It is almost impossible for any state to ignore the need for selective infrastructure and development incentives to either hold existing companies or attract new enterprises. From the perspective of public policymakers nationwide, the pursuit of commercial development of bioscience industry fits the objectives sought to diversify the economic base, generate new jobs, and improve the standard of living for citizens.

Industry Participants:
Industry collaboration with universities and policymakers is the hallmark of the vibrant U.S. technology industry growth over the past three decades. During that time period, industry moved to become an active participant in public policy creation by providing sights into its needs for sustained growth. Future state policymaker efforts to support the industry will require sustained industry input on the policy tools necessary for success. The symbiotic relationship between academia and industry is important not only for technology transfer purposes but for workforce development as well.

Bioscience Industry Partners and Roles Partners

DISCLAIMER: The examples cited in this document are only a small fraction of policies state governments have put in place to grow the bioscience industry. It is not intended to be exclusive of other policies to develop technology-based industries.

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024